Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.
Torii Pharmaceutical Dividend Announcement
• Torii Pharmaceutical announced a semi annually dividend of ¥60.00 per ordinary share which will be made payable on 2025-03-01. Ex dividend date: 2024-12-27
• Torii Pharmaceutical annual dividend for 2024 was ¥120.00
• Torii Pharmaceutical annual dividend for 2023 was ¥120.00
• Torii Pharmaceutical's trailing twelve-month (TTM) dividend yield is 3.17%
• Torii Pharmaceutical's dividend growth over the last five years (2018-2023) was 20.11% year
• Torii Pharmaceutical's dividend growth over the last ten years (2013-2023) was 11.61% year
Torii Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-12-27 | ¥60.00 | semi annually | 2025-03-01 |
2024-06-27 | ¥60.00 | semi annually | 2024-09-04 |
2023-12-28 | ¥70.00 | semi annually | 2024-03-28 |
2023-06-29 | ¥50.00 | semi annually | 2023-09-05 |
2022-12-29 | ¥76.00 | semi annually | 2023-03-29 |
2022-06-29 | ¥24.00 | semi annually | 2022-09-02 |
2021-12-29 | ¥24.00 | semi annually | 2022-03-30 |
2021-06-29 | ¥24.00 | semi annually | 2021-09-03 |
2020-12-29 | ¥24.00 | semi annually | 2021-03-26 |
2020-06-29 | ¥24.00 | semi annually | 2020-09-04 |
2019-12-27 | ¥24.00 | semi annually | 2020-03-27 |
2019-06-26 | ¥24.00 | semi annually | 2019-09-04 |
2018-12-26 | ¥24.00 | semi annually | 2019-03-27 |
2018-06-27 | ¥24.00 | semi annually | 2018-09-04 |
2017-12-27 | ¥24.00 | semi annually | 2018-03-29 |
2017-06-28 | ¥24.00 | semi annually | 2017-09-04 |
2016-12-28 | ¥24.00 | semi annually | |
2016-06-28 | ¥24.00 | semi annually | |
2015-12-28 | ¥24.00 | semi annually | |
2015-06-26 | ¥24.00 | semi annually | |
2014-12-26 | ¥20.00 | semi annually | |
2014-09-26 | ¥20.00 | semi annually | |
2014-03-27 | ¥20.00 | semi annually | |
2013-09-26 | ¥20.00 | semi annually | |
2013-03-27 | ¥20.00 | semi annually |
Torii Pharmaceutical Dividend per year
Torii Pharmaceutical Dividend growth
Torii Pharmaceutical Dividend Yield
Torii Pharmaceutical current trailing twelve-month (TTM) dividend yield is 3.17%. Interested in purchasing Torii Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Torii Pharmaceutical Financial Ratios
Torii Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Torii Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Torii Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Torii Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Torii Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Torii Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Torii Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Torii Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Torii Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Torii Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Torii Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Torii Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.